Effectiveness of Cardiovascular disease Specific Psychotherapy [CSP] on the stress, anxiety and depression of heart disease patients


1 Department of Psychology, Faculty of Psychology and Educational Sciences, Ferdowsi University of Mashhad, Mashhad, Iran

2 Department of Cardiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Introduction: Cardiovascular disease is one of the greatest widespread disease and the prevalence of it is increasing worldwide. Our understanding of the role of psychological factors in the incidence of the cardiovascular system has rapidly increased in the past few years. The purpose of this study was to determine the effectiveness of cardiovascular disease specific psychotherapy [CSP] on the stress, anxiety and depression of heart disease patients.Method: This research is a semi-experimental with experimental and control groups. To determine the number of the sample, at first, 30 participants from Rasol-e-Akram Hospital in Rasht were selected and were randomly assigned to two groups [cardiovascular specific psychotherapy] and control. DASS-21 scale were administered to both groups before and after training. Cardiovascular specific psychotherapy sessions were arranged for patients in 25 sessions twice a week for 2:30 hours. For controlling the intervention variable, multivariate analysis of covariance has been used in addiction to descriptive statistics. Data were analyzed through spss.20 software.Results: The results of MANCOVA showed that training significantly reduced the stress, anxiety and depression in the experimental group as compared with the control group.Conclusion: Results showed the cardiovascular disease specific psychotherapy [CSP] effects on the amount of stress, anxiety and depression in heart disease patients and this method can be used with usual medical care in the improvement and rehabilitation in cardiovascular diseases.The study is helpful for psychologists and other mental health professionals to help cardiovascular patients prevent the adverse effects of stress, anxiety and depression and is thus highly applicable to patients who have already become the victims of the stress related problems like anxiety and depression. Keywords: Stress, Anxiety, Depression, Cardiovascular Diseases, Psychotherapy

  1. Sepanlou SG, Newson RB, Poustchi H, Malekzadeh MM, Rezanejad Asl P, Etemadi A, et al. Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran. Arch Iran Med. 2015 Mar;18(3):144–52.
  2. George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, et al. How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1,937,360 People. Circulation. 2015 Oct 6;132(14):1320–8.
  3. Estebsari F, Taghdisi MH, Mostafaei D, Jamshidi E, Latifi M. Determining the Factors Contributing to Quality of Life of Patients at the Last Stage of Life: A Qualitative Study. Iran Red Crescent Med J [Internet]. 2013 Dec [cited 2016 Jan 21];15(12). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955507/
  4. Ibraeva LK, Azhimetova GN, Amanbekova AU, Bakirova RE. [Cardiovascular diseases in the population of industrial towns and environmental factors]. Ter Arkh. 2015;87(1):76–8.
  5. Akhtar S, Asghar N. Risk factors of cardiovascular disease in district Swat. J Pak Med Assoc. 2015 Sep;65(9):1001–4.
  6. Ose D, Rochon J, Campbell SM, Wensing M, Freund T, van Lieshout J, et al. Health-related quality of life and risk factor control: the importance of educational level in prevention of cardiovascular diseases. Eur J Public Health. 2014 Aug;24(4):679–84.
  7. Lu X, Huang J, Wang L, Chen S, Yang X, Li J, et al. Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese. Hypertension. 2015 Oct;66(4):786–92.
  8. Bomhof-Roordink H, Seldenrijk A, van Hout HPJ, van Marwijk HWJ, Diamant M, Penninx BWJH. Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms. J Psychosom Res. 2015 Apr;78(4):332–9.
  9. Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015 Sep;278(3):238–50.
  10. Myers J, McAuley P, Lavie CJ, Despres J-P, Arena R, Kokkinos P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis. 2015 Feb;57(4):306–14.
  11. Scholl J, Bots ML, Peters S A. E. Contribution of cardiorespiratory fitness, relative to traditional cardiovascular disease risk factors, to common carotid intima-media thickness. J Intern Med. 2015 Apr;277(4):439–46.
  12. Goldstein KM, Melnyk SD, Zullig LL, Stechuchak KM, Oddone E, Bastian LA, et al. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans. Womens Health Issues. 2014 Oct;24(5):477–83.
  13. Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Cochrane Database Syst Rev. 2015;8:CD011163.
  14. Reinikainen J, Laatikainen T, Karvanen J, Tolonen H. Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up study in Finland. Int J Epidemiol. 2015 Feb;44(1):108–16.
  15. Robbins CL, Keyserling TC, Jilcott Pitts S, Morrow J, Moos M-K, Johnston LF, et al. Outcomes of cardiovascular disease risk factor screening and referrals in a family planning clinic. J Womens Health (Larchmt). 2015 Feb;24(2):131–7.
  16. Tan MP, Morgan K. Psychological interventions in cardiovascular disease: an update. Curr Opin Psychiatry. 2015 Sep;28(5):371–7.
  17. Appleton AA, Loucks EB, Buka SL, Kubzansky LD. Divergent associations of antecedent- and response-focused emotion regulation strategies with midlife cardiovascular disease risk. Ann Behav Med. 2014 Oct;48(2):246–55.
  18. Szerencsi K, van Amelsvoort L, Prins M, Kant I. The prospective relationship between work stressors and cardiovascular disease, using a comprehensive work stressor measure for exposure assessment. Int Arch Occup Environ Health. 2014 Feb;87(2):155–64.
  19. Lee WWM, Choi KC, Yum RWY, Yu DSF, Chair SY. Effectiveness of motivational interviewing on lifestyle modification and health outcomes of clients at risk or diagnosed with cardiovascular diseases: A systematic review. Int J Nurs Stud. 2016 Jan; 53:331–41.
  20. Batelaan NM, ten Have M, van Balkom AJLM, Tuithof M, de Graaf R. Anxiety disorders and onset of cardiovascular disease: the differential impact of panic, phobias and worry. J Anxiety Disord. 2014 Mar;28(2):252–8.
  21. Hartley L, Dyakova M, Holmes J, Clarke A, Lee MS, Ernst E, et al. Yoga for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;5:CD010072.
  22. Canivet C, Nilsson PM, Lindeberg SI, Karasek R, Östergren P-O. Insomnia increases risk for cardiovascular events in women and in men with low socioeconomic status: a longitudinal, register-based study. J Psychosom Res. 2014 Apr;76(4):292–9.
  23. Gallo LC, Roesch SC, Fortmann AL, Carnethon MR, Penedo FJ, Perreira K, et al. Associations of chronic stress burden, perceived stress, and traumatic stress with cardiovascular disease prevalence and risk factors in the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study. Psychosom Med. 2014 Aug;76(6):468–75.
  24. Yammine L, Kang D-H, Baun MM, Meininger JC. Endothelin-1 and psychosocial risk factors for cardiovascular disease: a systematic review. Psychosom Med. 2014 Feb;76(2):109–21.
  25. Inoue N. Stress and atherosclerotic cardiovascular disease. J Atheroscler Thromb. 2014;21(5):391–401.
  26. Bokenberger K, Pedersen NL, Gatz M, Dahl AK. The type A behavior pattern and cardiovascular disease as predictors of dementia. Health Psychol. 2014 Dec;33(12):1593–601.
  27. Mondelli V, Pariante CM. On the heart, the mind, and how inflammation killed the Cartesian dualism. Commentary on the 2015 Named Series: Psychological Risk Factors and Immune System Involvement in Cardiovascular Disease. Brain Behav Immun. 2015 Nov; 50:14–7.
  28. Halaris A. Co-morbidity between cardiovascular pathology and depression: role of inflammation. Mod Trends Pharmacopsychiatri. 2013; 28:144–61.
  29. Lagraauw HM, Kuiper J, Bot I. Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies. Brain Behav Immun. 2015 Nov; 50:18–30.
  30. Menezes AR, Lavie CJ, Milani RV, O’Keefe J, Lavie TJ. Psychological risk factors and cardiovascular disease: is it all in your head? Postgrad Med. 2011 Sep;123(5):165–76.
  31. Golbidi S, Frisbee JC, Laher I. Chronic stress impacts the cardiovascular system: animal models and clinical outcomes. Am J Physiol Heart Circ Physiol. 2015 Jun 15;308(12):H1476–98.
  32. Dos Reis DG, Fortaleza EAT, Tavares RF, Corrêa FMA. Role of the autonomic nervous system and baroreflex in stress-evoked cardiovascular responses in rats. Stress. 2014 Jul;17(4):362–72.
  33. Hering D, Lachowska K, Schlaich M. Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. Curr Hypertens Rep. 2015 Oct;17(10):80.
  34. Dragomir AI, Gentile C, Nolan RP, D’Antono B. Three-year stability of cardiovascular and autonomic nervous system responses to psychological stress. Psychophysiology. 2014 Sep;51(9):921–31.
  35. May RW, Sanchez-Gonzalez MA, Brown PC, Koutnik AP, Fincham FD. School burnout and cardiovascular functioning in young adult males: a hemodynamic perspective. Stress. 2014 Jan;17(1):79–87.
  36. Cuffee Y, Ogedegbe C, Williams NJ, Ogedegbe G, Schoenthaler A. Psychosocial risk factors for hypertension: an update of the literature. Curr Hypertens Rep. 2014 Oct;16(10):483.
  37. Kaur H, Luckhaupt SE, Li J, Alterman T, Calvert GM. Workplace psychosocial factors associated with hypertension in the U.S. workforce: a cross-sectional study based on the 2010 national health interview survey. Am J Ind Med. 2014 Sep;57(9):1011–21.
  38. Boateng GO, Luginaah IN, Taabazuing M-M. Examining the Risk Factors Associated with Hypertension Among the Elderly in Ghana. J Aging Health. 2015 Oct;27(7):1147–69.
  39. Steptoe A, Kivimäki M. Stress and Cardiovascular Disease: An Update on Current Knowledge. Annual Review of Public Health. 2013;34(1):337–54.
  40. Backe E-M, Seidler A, Latza U, Rossnagel K, Schumann B. The role of psychosocial stress at work for the development of cardiovascular diseases: a systematic review. Int Arch Occup Environ Health. 2012 Jan;85(1):67–79.
  41. Walton KG, Schneider RH, Nidich SI, Salerno JW, Nordstrom CK, Merz CNB. Psychosocial Stress and Cardiovascular Disease Part 2: Effectiveness of the Transcendental Meditation Program in Treatment and Prevention. Behav Med. 2002;28(3):106–23.
  42. Byles JE, Robinson I, Banks E, Gibson R, Leigh L, Rodgers B, et al. Psychological distress and comorbid physical conditions: disease or disability? Depress Anxiety. 2014 Jun;31(6):524–32.
  43. Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. Low socioeconomic status and psychological distress as synergistic predictors of mortality from stroke and coronary heart disease. Psychosom Med. 2013 Apr;75(3):311–6.
  44. Razvodovsky YE. Psychosocial distress as a risk factor of ischemic heart disease mortality. Psychiatr Danub. 2013 Mar;25(1):68–75.
  45. Habibović M, Versteeg H, Pelle AJM, Theuns DAMJ, Jordaens L, Pedersen SS. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace. 2013 Mar;15(3):355–61.
  46. Tully PJ, Cosh SM, Baumeister H. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res. 2014 Dec;77(6):439–48.
  47. Tully PJ, Cosh SM, Baune BT. A review of the effects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol Health Med. 2013;18(6):627–44.
  48. Dixon T, Lim LL, Powell H, Fisher JD. Psychosocial experiences of cardiac patients in early recovery: a community-based study. J Adv Nurs. 2000 Jun;31(6):1368–75.
  49. Rafael B, Konkolÿ Thege B, Kovacs P, Balog P. [Anxiety, depression, health-related control beliefs, and their association with health behavior in patients with ischemic heart disease]. Orv Hetil. 2015 May 17;156(20):813–22.
  50. Rothenbacher D, Jaensch A, Mons U, Hahmann H, Becker T, Koenig W, et al. Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need. Eur J Prev Cardiol. 2015 Sep;22(9):1129–38.
  51. Chalmers JA, Quintana DS, Abbott MJ-A, Kemp AH. Anxiety Disorders Are Associated with Reduced Heart Rate Variability: A Meta-Analysis. Front Psychiatry. 2014; 5:80.
  52. Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015 Jan;141(1):176–212.
  53. Goldstein BI, Carnethon MR, Matthews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2015 Sep 8;132(10):965–86.
  54. Kang H-J, Stewart R, Bae K-Y, Kim S-W, Shin I-S, Hong YJ, et al. Predictors of depressive disorder following acute coronary syndrome: Results from K-DEPACS and EsDEPACS. J Affect Disord. 2015 Aug 1; 181:1–8.
  55. Alderson SL, Russell AM, McLintock K, Potrata B, House A, Foy R. Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study. BMJ Open. 2014;4(8): e005146.
  56. Ren Y, Yang H, Browning C, Thomas S, Liu M. Performance of screening tools in detecting major depressive disorder among patients with coronary heart disease: a systematic review. Med Sci Monit. 2015; 21:646–53.
  57. Kozdağ G, Yaluğ İ, İnan N, Ertaş G, Selekler M, Kutlu H, et al. Major depressive disorder in chronic heart failure patients: Does silent cerebral infarction cause major depressive disorder in this patient population? Turk Kardiyol Dern Ars. 2015 Sep;43(6):505–12.
  58. Blumenfield M, Suojanen JK, Weiss C. Public awareness about the connection between depression and physical health: specifically, heart disease. Psychiatr Q. 2012 Sep;83(3):259–69.
  59. Halaris A. Inflammation, heart disease, and depression. Curr Psychiatry Rep. 2013 Oct;15(10):400.
  60. Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014; 14:371.
  61. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med. 2002 Jul;23(1):51–61.
  62. Charlson FJ, Moran AE, Freedman G, Norman RE, Stapelberg NJC, Baxter AJ, et al. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 2013; 11:250.
  63. Wang A-L, Chen Z, Luo J, Shang Q-H, Xu H. Systematic review on randomized controlled trials of coronary heart disease complicated with depression treated with Chinese herbal medicines. Chin J Integr Med. 2016 Jan;22(1):56–66.
  64. Quadri E, Farè C, Palmero E, Campioni G, Chessa M, Callus E. [Art therapy for hospitalised congenital heart disease patients: a method of psychological intervention at the IRCCS Policlinico San Donato Milanese Hospital]. Pediatr Med Chir. 2012 Dec;34(6):292–6.
  65. Younge JO, Wery MF, Gotink RA, Utens EMWJ, Michels M, Rizopoulos D, et al. Web-Based Mindfulness Intervention in Heart Disease: A Randomized Controlled Trial. PLoS ONE. 2015;10(12): e0143843.
  66. Davies AK, McGale N, Humphries SE, Hirani SP, Beaney KE, Bappa DAS, et al. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial. Trials. 2015;16(1):547.
  67. Cramer H, Lauche R, Haller H, Dobos G, Michalsen A. A systematic review of yoga for heart disease. Eur J Prev Cardiol. 2015 Mar;22(3):284–95.
  68. Whalley B, Rees K, Davies P, Bennett P, Ebrahim S, Liu Z, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2011;(8):CD002902.
  69. Klein DM, Turvey CL, Pies CJ. Relationship of coping styles with quality of life and depressive symptoms in older heart failure patients. J Aging Health. 2007 Feb;19(1):22–38.
  70. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res. 2000 May;48(4-5):379–91.
  71. de Jonge P, Ormel J, van den Brink RHS, van Melle JP, Spijkerman TA, Kuijper A, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry. 2006 Jan;163(1):138–44.
  72. Pignay-Demaria V, Lesperance F, Demaria RG, Frasure-Smith N, Perrault LP. Depression and anxiety and outcomes of coronary artery bypass surgery. Ann Thorac Surg. 2003 Jan;75(1):314–21.
  73. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175–91.
  74. Tonsing KN. Psychometric properties and validation of Nepali version of the Depression Anxiety Stress Scales (DASS-21). Asian J Psychiatr. 2014 Apr; 8:63–6.
  75. Sahebi A, Asghari MJ, Salari R. Validation of depression, anxiety and stress (DASS-21) for Iranian population. Iran Psychol. 2005;(1):50–60.
  76. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svärdsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med. 2011 Jan 24;171(2):134–40.
  77. Manzoni GM, Cesa GL, Bacchetta M, Castelnuovo G, Conti S, Gaggioli A, et al. Virtual Reality-Enhanced Cognitive-Behavioral Therapy for Morbid Obesity: A Randomized Controlled Study with 1 Year Follow-Up. Cyberpsychol Behav Soc Netw. 2015 Oct 2;
  78. Doering LV, McGuire A, Eastwood J-A, Chen B, Bodan RC, Czer LS, et al. Cognitive behavioral therapy for depression improves pain and perceived control in cardiac surgery patients. Eur J Cardiovasc Nurs. 2015 Jun 26;
  79. Lundgren J, Andersson G, Dahlström Ö, Jaarsma T, Köhler AK, Johansson P. Internet-based cognitive behavior therapy for patients with heart failure and depressive symptoms: A proof of concept study. Patient Educ Couns. 2015 Aug;98(8):935–42.
  80. Athilingam P, Edwards JD, Valdes EG, Ji M, Guglin M. Computerized auditory cognitive training to improve cognition and functional outcomes in patients with heart failure: Results of a pilot study. Heart Lung. 2015 Apr;44(2):120–8.
  81. Hannesdottir DK, Ollendick TH. The role of emotion regulation in the treatment of child anxiety disorders. Clin Child Fam Psychol Rev. 2007 Sep;10(3):275–93.
  82. Martin RC, Dahlen ER. Cognitive emotion regulation in the prediction of depression, anxiety, stress, and anger. Personality and Individual Differences. 2005 Nov;39(7):1249–60.
  83. Patron E, Messerotti Benvenuti S, Favretto G, Gasparotto R, Palomba D. Depression and reduced heart rate variability after cardiac surgery: the mediating role of emotion regulation. Auton Neurosci. 2014 Feb; 180:53–8.
  84. Patron E, Messerotti Benvenuti S, Favretto G, Valfrè C, Bonfà C, Gasparotto R, et al. Association between depression and heart rate variability in patients after cardiac surgery: a pilot study. J Psychosom Res. 2012 Jul;73(1):42–6.
  85. Wang Y, Zhao X, O’Neil A, Turner A, Liu X, Berk M. Altered cardiac autonomic nervous function in depression. BMC Psychiatry. 2013; 13:187.
  86. Goldstein BI, Carnethon MR, Matthews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2015 Sep 8;132(10):965–86.
  87. Graven LJ, Grant JS. Social support and self-care behaviors in individuals with heart failure: an integrative review. Int J Nurs Stud. 2014 Feb;51(2):320–33.
  88. Schmidt NB, Wollaway-Bickel K, Trakowski JH, Santiago HT, Vasey M. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behav Res Ther. 2002 Jan;40(1):67–73.